Wanxin Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Wanxin Liu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Baohua Shi
Department of Orthopedics, Chongming Branch, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 202157, China
1 shared publication - Chengzhe Zhang
Department of Orthopedics, Chongming Branch, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 202157, China
1 shared publication - Dong Zhang
Department of Orthopedics, Chongming Branch, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 202157, China
1 shared publication - Haitao Gong
Department of Orthopedics, Chongming Branch, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 202157, China
1 shared publication - Hui Lian
Department of Orthopedics, Chongming Branch, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 202157, China
1 shared publication - Jiaming Zhang
School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by XMLink in Nutrition Research and Practice
- Vol. 19 (4) , 525-536
Cistanche deserticola polysaccharide alleviates spinal cord injury in mice by inhibiting NLRP3 inflammasome activation
Spinal cord injury (SCI) is a severe trauma in the central nervous system (CNS) that not only affects human health but also imposes a significant burden on families. Several herbal extracts have been ascertained to regulate SCI progression. Cistanche deserticola polysaccharide (CDP), extracted from C. deserticola, exhibits beneficial effects in a variety of diseases. However, the regulatory roles and associated pathways of CDP in the SCI progression remains unclear. The SCI animal model was successfully established. The Basso-Beattie-Bresnahan scores were determined through locomotion recovery assessment. Histopathological changes in spinal cord tissues were confirmed through hematoxylin eosin staining, while the number of Nissl bodies in ventral horn of spinal cord was verified through Nissl staining. The levels of malondialdehyde, superoxide dismutase, glutathione peroxidase, and catalase were quantified using commercial assay kits. The expression of ionized calcium-binding adapter molecule 1 (Iba-1) or nuclear factor erythroid 2-related factor 2 (Nrf2) was evaluated through immunofluorescence assay, and the protein expressions were inspected through western blot analysis. CDP treatment significantly improved the histopathological damage of spinal cord tissues following SCI. Additionally, CDP alleviated oxidative stress in spinal cord tissue. It also alleviated microglia activation by reducing Iba-1 expression. Mechanistically, CDP triggered the Nrf2 signaling pathway, which in turn suppressed NLR family pyrin domain containing 3 (NLRP3) inflammasome activation, as proved through rescue assays. CDP alleviates SCI in mice by inhibiting NLRP3 inflammasome activation via the Nrf2 pathway. This finding suggested that CDP may serve as a promising drug for ameliorating SCI.
- 1 January 2025
- Published by XMLink in Nutrition Research and Practice
- Vol. 19 (4) , 525-536
Open AccessCistanche deserticola polysaccharide alleviates spinal cord injury in mice by inhibiting NLRP3 inflammasome activation
Spinal cord injury (SCI) is a severe trauma in the central nervous system (CNS) that not only affects human health but also imposes a significant burden on families. Several herbal extracts have been ascertained to regulate SCI progression. Cistanche deserticola polysaccharide (CDP), extracted from C. deserticola, exhibits beneficial effects in a variety of diseases. However, the regulatory roles and associated pathways of CDP in the SCI progression remains unclear. The SCI animal model was successfully established. The Basso-Beattie-Bresnahan scores were determined through locomotion recovery assessment. Histopathological changes in spinal cord tissues were confirmed through hematoxylin eosin staining, while the number of Nissl bodies in ventral horn of spinal cord was verified through Nissl staining. The levels of malondialdehyde, superoxide dismutase, glutathione peroxidase, and catalase were quantified using commercial assay kits. The expression of ionized calcium-binding adapter molecule 1 (Iba-1) or nuclear factor erythroid 2-related factor 2 (Nrf2) was evaluated through immunofluorescence assay, and the protein expressions were inspected through western blot analysis. CDP treatment significantly improved the histopathological damage of spinal cord tissues following SCI. Additionally, CDP alleviated oxidative stress in spinal cord tissue. It also alleviated microglia activation by reducing Iba-1 expression. Mechanistically, CDP triggered the Nrf2 signaling pathway, which in turn suppressed NLR family pyrin domain containing 3 (NLRP3) inflammasome activation, as proved through rescue assays. CDP alleviates SCI in mice by inhibiting NLRP3 inflammasome activation via the Nrf2 pathway. This finding suggested that CDP may serve as a promising drug for ameliorating SCI.
- Open Access
- 7 April 2021
- Published by Taylor & Francis in Future Virology
- Vol. 16 (4) , 265-276
Abnormal Myocardial Enzymes are Important Indicators of Poor Prognosis in COVID-19 Patients
Objective: Researching the prognostic value of myocardial enzymes in COVID-19 patients. Materials & methods: We collected 113 confirmed COVID-19 patients. The dynamic changes of CK, LDH and α-HBDH ...
- 7 April 2021
- Published by Taylor & Francis in Future Virology
- Vol. 16 (4) , 265-276
Open AccessAbnormal Myocardial Enzymes are Important Indicators of Poor Prognosis in COVID-19 Patients
Objective: Researching the prognostic value of myocardial enzymes in COVID-19 patients. Materials & methods: We collected 113 confirmed COVID-19 patients. The dynamic changes of CK, LDH and α-HBDH ...
- 18 March 2019
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 100 (6) , 1431-1439
Endo-siRNAs regulate early embryonic development by inhibiting transcription of long terminal repeat sequence in pig†
Activity of some endogenous retroviruses (ERVs) has been proven to be important for development of early mammalian embryo. However, abnormal activation of ERVs can also cause genetic diseases due to their ability to retrotranspose, so the regulatory mechanism to limit transcription of ERVs needs to be clarified. Endogenous small interfering RNA (endo-siRNA) has been reported to protect cells against transposable elements (TEs). Here, we determined the role of ERVs long terminal repeat sequences (LTRs) derived endo-siRNAs (LTR-siRNAs) on inhibition of the activity of ERVs during early embryonic development in pig. 7 most highly expressed LTR-siRNAs were identified in porcine zygote by high-throughput small RNA sequencing. We verified that the biogenesis of the LTRs-siRNAs was DICER-dependent and they were generated from double-stranded RNA (dsRNA) formed by sense and antisense transcripts of LTRs. And, the expression of sense and antisense of LTRs might be due to the loss of DNA methylation at some LTRs locus. Furthermore, we showed that the LTR-siRNAs could regulate early embryonic development by repression of LTRs expression at a post-transcriptional level. So, we propose here, during early embryonic development when epigenetic reprogramming occurs, endo-siRNA pathway act as a sophisticated balance of regulatory mechanism for ERVs activity.
- 18 March 2019
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 100 (6) , 1431-1439
Endo-siRNAs regulate early embryonic development by inhibiting transcription of long terminal repeat sequence in pig†
Activity of some endogenous retroviruses (ERVs) has been proven to be important for development of early mammalian embryo. However, abnormal activation of ERVs can also cause genetic diseases due to their ability to retrotranspose, so the regulatory mechanism to limit transcription of ERVs needs to be clarified. Endogenous small interfering RNA (endo-siRNA) has been reported to protect cells against transposable elements (TEs). Here, we determined the role of ERVs long terminal repeat sequences (LTRs) derived endo-siRNAs (LTR-siRNAs) on inhibition of the activity of ERVs during early embryonic development in pig. 7 most highly expressed LTR-siRNAs were identified in porcine zygote by high-throughput small RNA sequencing. We verified that the biogenesis of the LTRs-siRNAs was DICER-dependent and they were generated from double-stranded RNA (dsRNA) formed by sense and antisense transcripts of LTRs. And, the expression of sense and antisense of LTRs might be due to the loss of DNA methylation at some LTRs locus. Furthermore, we showed that the LTR-siRNAs could regulate early embryonic development by repression of LTRs expression at a post-transcriptional level. So, we propose here, during early embryonic development when epigenetic reprogramming occurs, endo-siRNA pathway act as a sophisticated balance of regulatory mechanism for ERVs activity.